Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick R Appelbaum

Showing results (111-120 of 339) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2005
Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and olderHerschel Wallen, Theodore A Gooley, H Joachim Deeg, et al.
Blood|June 26, 2004
Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemiaWilliam Tse, Soheil Meshinchi, Todd A Alonzo, et al.
Blood|February 22, 2003
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimenJerald P Radich, Ted Gooley, William Bensinger, et al.
Hematology. American Society of Hematology. Education Program|November 26, 2002
Acute lymphoblastic leukemiaDieter Hoelzer, Nicola Gökbuget, Oliver Ottmann, et al.
Leukemia|January 27, 2025
Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203Megan Othus, Guillermo Garcia-Manero, Frederick R Appelbaum, et al.
Leukemia Research and Treatment|April 30, 2014
Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemiaMerav Bar, Brent L Wood, Jerald P Radich, et al.
British Journal of Haematology|July 22, 2014
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemiaAnjali S Advani, Shannon McDonough, Edward Copelan, et al.
Blood|August 15, 2002
Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phaseAlan F List, Kenneth J Kopecky, Cheryl L Willman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
Gemtuzumab ozogamicin: time to resurrect?Farhad Ravandi, Elihu H Estey, Frederick R Appelbaum, et al.
Blood|February 4, 2006
Age and acute myeloid leukemiaFrederick R Appelbaum, Holly Gundacker, David R Head, et al.
Pageof 34

Showing results (111-120 of 339) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2005
Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and olderHerschel Wallen, Theodore A Gooley, H Joachim Deeg, et al.
Blood|June 26, 2004
Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemiaWilliam Tse, Soheil Meshinchi, Todd A Alonzo, et al.
Blood|February 22, 2003
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimenJerald P Radich, Ted Gooley, William Bensinger, et al.
Hematology. American Society of Hematology. Education Program|November 26, 2002
Acute lymphoblastic leukemiaDieter Hoelzer, Nicola Gökbuget, Oliver Ottmann, et al.
Leukemia|January 27, 2025
Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203Megan Othus, Guillermo Garcia-Manero, Frederick R Appelbaum, et al.
Leukemia Research and Treatment|April 30, 2014
Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemiaMerav Bar, Brent L Wood, Jerald P Radich, et al.
British Journal of Haematology|July 22, 2014
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemiaAnjali S Advani, Shannon McDonough, Edward Copelan, et al.
Blood|August 15, 2002
Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phaseAlan F List, Kenneth J Kopecky, Cheryl L Willman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2012
Gemtuzumab ozogamicin: time to resurrect?Farhad Ravandi, Elihu H Estey, Frederick R Appelbaum, et al.
Blood|February 4, 2006
Age and acute myeloid leukemiaFrederick R Appelbaum, Holly Gundacker, David R Head, et al.
Pageof 34